222 related articles for article (PubMed ID: 24065244)
1. Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response.
Battinelli EM; Markens BA; Kulenthirarajan RA; Machlus KR; Flaumenhaft R; Italiano JE
Blood; 2014 Jan; 123(1):101-12. PubMed ID: 24065244
[TBL] [Abstract][Full Text] [Related]
2. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
3. PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.
Huang Z; Miao X; Luan Y; Zhu L; Kong F; Lu Q; Pernow J; Nilsson G; Li N
J Thromb Haemost; 2015 Mar; 13(3):465-76. PubMed ID: 25495701
[TBL] [Abstract][Full Text] [Related]
4. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
Bambace NM; Levis JE; Holmes CE
Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
Etulain J; Mena HA; Negrotto S; Schattner M
Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.
Johnson KE; Forward JA; Tippy MD; Ceglowski JR; El-Husayni S; Kulenthirarajan R; Machlus KR; Mayer EL; Italiano JE; Battinelli EM
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):664-674. PubMed ID: 28153880
[TBL] [Abstract][Full Text] [Related]
7. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.
Battinelli EM; Markens BA; Italiano JE
Blood; 2011 Aug; 118(5):1359-69. PubMed ID: 21680800
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Platelets Selectively Activated by Protease-Activated Receptors on Meniscal Cells.
Xu H; Zou X; Xia P; Aboudi MAK; Chen R; Huang H
Am J Sports Med; 2020 Jan; 48(1):197-209. PubMed ID: 31765237
[TBL] [Abstract][Full Text] [Related]
9. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin.
Etulain J; Fondevila C; Negrotto S; Schattner M
Br J Pharmacol; 2013 Sep; 170(2):255-65. PubMed ID: 23713888
[TBL] [Abstract][Full Text] [Related]
10. Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release.
Di Vito C; Navone SE; Marfia G; Abdel Hadi L; Mancuso ME; Pecci A; Crisà FM; Berno V; Rampini P; Campanella R; Riboni L
Platelets; 2017 Sep; 28(6):585-594. PubMed ID: 27897101
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State.
Gatsiou A; Sopova K; Tselepis A; Stellos K
Cells; 2021 Jul; 10(8):. PubMed ID: 34440624
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets.
Verheul HM; Jorna AS; Hoekman K; Broxterman HJ; Gebbink MF; Pinedo HM
Blood; 2000 Dec; 96(13):4216-21. PubMed ID: 11110694
[TBL] [Abstract][Full Text] [Related]
13. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
15. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli.
Chatterjee M; Huang Z; Zhang W; Jiang L; Hultenby K; Zhu L; Hu H; Nilsson GP; Li N
Blood; 2011 Apr; 117(14):3907-11. PubMed ID: 21330475
[TBL] [Abstract][Full Text] [Related]
16. Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet Hyperreactivity.
Miao X; Zhang W; Huang Z; Li N
PLoS One; 2016; 11(9):e0162405. PubMed ID: 27612088
[TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist.
Hawes BE; Zhai Y; Hesk D; Wirth M; Wei H; Chintala M; Seiffert D
Eur J Pharmacol; 2015 Sep; 762():221-8. PubMed ID: 26022529
[TBL] [Abstract][Full Text] [Related]
18. The angiogenic responses induced by release of angiogenic proteins from tumor cell-activated platelets are regulated by distinct molecular pathways.
Wu H; Fan F; Liu Z; Zhang F; Liu Y; Wei Z; Shen C; Cao Y; Wang A; Lu Y
IUBMB Life; 2015 Aug; 67(8):626-33. PubMed ID: 26283102
[TBL] [Abstract][Full Text] [Related]
19. Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin.
Rousseau A; Van Dreden P; Mbemba E; Elalamy I; Larsen A; Gerotziafas GT
Thromb Res; 2015 Dec; 136(6):1273-9. PubMed ID: 26489727
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma.
Gerotziafas GT; Depasse F; Chakroun T; Van Dreden P; Samama MM; Elalamy I
Blood Coagul Fibrinolysis; 2004 Mar; 15(2):149-56. PubMed ID: 15091002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
